Lobbying activity

1A

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Tariff (miscellaneous tariff bills), Agriculture, Budget/Appropriations, Copyright/Patent/Trademark

View → 4A

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Natural Resources, Environment/Superfund, Labor Issues/Antitrust/Workplace, Foreign Relations

View → 2T

WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code

View → 2T

THE VOGEL GROUP for FORTRESS BIOTECH INC.

2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate

Health Issues

View → Q2

BIOGEN for BIOGEN

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

View → Q2

STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate

Health Issues

View → Q2

NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Defense, Budget/Appropriations

View → Q2

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs

View → Q2

MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income

Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Taxation/Internal Revenue Code

View → Q2

TOURETTE ASSOCIATION OF AMERICA for TOURETTE ASSOCIATION OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Education, Health Issues, Medicare/Medicaid

View → Q2

NOVARTIS for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q2

AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Small Business, Health Issues

View → Q2

TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid

View → Q2

THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $40,000.00 income

Pharmacy

View → Q2

SMITHBUCKLIN CORPORATION for ASTCT

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $70,000.00 income

Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid

View → Q2

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues

View → 4A

BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate

Pharmacy

View → Q2

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

BRACEWELL LLP for AQUESTIVE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · Indiana · House · Senate · $60,000.00 income

Consumer Issues/Safety/Products, Health Issues

View → Q2

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Defense, Medicare/Medicaid, Health Issues

View → Q2

BRACEWELL LLP for NATIONAL BRAIN TUMOR SOCIETY

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $20,000.00 income

Defense, Budget/Appropriations, Health Issues

View → Q2

NATIONWIDE CHILDREN'S HOSPITAL, INC. for NATIONWIDE CHILDREN'S HOSPITAL INC

2nd Quarter (Apr 1 - June 30) 2026 · Ohio · House · Senate

Health Issues, Medicare/Medicaid

View → Q2

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate

Health Issues

View →